Abstract
We retrospectively investigated the prevalence of drug resistance in Mycobacterium tuberculosis (MTB) isolates recovered from elderly patients and compared the drug resistance patterns between the elderly (≥65 years old) and adult (15–64 years old) patients. Data on the prevalence of drug resistance in clinical and non-duplicate isolates of MTB recovered from 2000 to 2008 were evaluated. Among the 3,186 non-duplicate MTB isolates found during the study period, 1,497 isolates were recovered from elderly patients. Thirty-eight (2.54%) isolates were multidrug-resistant tuberculosis (MDRTB). The rates of resistance to isoniazid (INH), rifampicin (RIF), ethambutol (EMB), streptomycin (SM), ofloxacin, rifabutin, any one drug-resistant (ADR), and multidrug-resistant (MDR) were significantly lower in isolates from the elderly than from adults (p < 0.05). Significant decreasing trends in resistance rates to EMB, SM, at least any one of the four first-line agents (ADR), and MDRTB were observed (p < 0.05) . In conclusion, elderly patients had a lower rate of anti-TB drug resistance than adults and a decreasing overall trend of anti-TB drug resistance was found in the elderly in recent years, but the higher rate of MDRTB in Taiwan continues to present a challenge for the control of TB in the elderly.
Similar content being viewed by others
References
Tocque K, Bellis MA, Tam CM, Chan SL, Syed Q, Remmington T et al (1998) Long-term trends in tuberculosis. Comparison of age–cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med 158:484–488
Stead WW, Lofgren JP (1983) Does the risk of tuberculosis increase in old age? J Infect Dis 147:951–955
Davies PD (1994) Tuberculosis in the elderly. J Antimicrob Chemother 34:93–100
Yu MC, Bai KJ, Chang JH, Lee CN (2006) Age transition of tuberculosis patients in Taiwan, 1957–2001. J Formos Med Assoc 105:25–30
Dahmash NS, Fayed DF, Chowdhury MN, Arora SC (1995) Diagnostic challenge of tuberculosis of the elderly in hospital: experience at a university hospital in Saudi Arabia. J Infect 31:93–97
Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ et al (2008) The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 36:335–340
Su WJ, Feng JY, Huang CC, Perng RP (2008) Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan. J Formos Med Assoc 107:259–264
Liaw YS, Hsueh PR, Yu CJ, Wang SK, Yang PC, Luh KT (2004) Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998–2002. J Formos Med Assoc 103:671–677
Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG et al (2002) Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999. Thorax 57:477–482
Wang JY, Lee LN, Chou CS, Huang CY, Wang SK, Lai HC et al (2004) Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol 42:4599–4603
Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC et al (2008) Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan. Clin Infect Dis 47:e57–e63
Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Chou CH et al (2010) Clinical and genotypic characteristics of extensively drug-resistant and multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis 29:597–600
National Committee for Clinical Laboratory Standards (NCCLS) (2003) Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard. NCCLS, Wayne, PA, USA
Centers for Disease Control and Prevention (CDC) (2006) Revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 55:1176
Centers for Disease Control and Prevention (CDC) (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 55:301–305
Liaw YS, Yang PC, Yu CJ, Wu ZG, Chang DB, Lee LN et al (1995) Clinical spectrum of tuberculosis in older patients. J Am Geriatr Soc 43:256–260
Yu MC, Suo J, Chiang CY, Bai KJ, Lin TP, Luh KT (1997) Initial drug resistance of Mycobacterium tuberculosis in Taiwan. J Formos Med Assoc 96:890–894
Lu PL, Lee YW, Peng CF, Tsai JJ, Chen YH, Hwang KP et al (2003) The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996–2000. Int J Antimicrob Agents 21:239–243
Wang PD, Lin RS (2001) Drug-resistant tuberculosis in Taipei, 1996–1999. Am J Infect Control 29:41–47
Kam KM, Yip CW (2001) Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986–1999, after the implementation of directly observed treatment. Int J Tuberc Lung Dis 5:815–823
Al-Tawfiq JA, Al-Muraikhy AA, Abed MS (2005) Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. Chest 128:3229–3232
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, WL., Lai, CC., Tan, CK. et al. Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000–2008. Eur J Clin Microbiol Infect Dis 29, 1413–1416 (2010). https://doi.org/10.1007/s10096-010-1019-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-010-1019-7